The Department of Health (DoH) will convene this week an independent panel that will review the results of the clinical trials of Dengvaxia, Health Secretary Francisco Duque said on Tuesday.
Duque said the team will review the results of the five-year observation period found in clinical trials as well as data from the post-marketing surveillance of the Food and Drug Administration and the post-immunization report of the department’s Epidemiology bureau.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.